Financials in USD. Standardized financial statements.
A compact view of how Panacea Life Sciences Holdings, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $910,518 | $4.11M | $2.38M | $1.63M | $2.06M | $9.02M | $345,680 | $0 | $0 | $0 |
| Revenue Growth? | -77.8% | +72.2% | +46.6% | -21.0% | -77.2% | +2508.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $2.13M | $1.26M | $6.47M | $1.23M | $1.52M | $7.02M | $2.05M | $0 | $0 | $0 |
| Gross Profit? | -$1.22M | $2.85M | -$4.09M | $396,470 | $540,578 | $2.00M | -$1.70M | $0 | $0 | $0 |
| Gross Margin? | -133.9% | +69.4% | -171.5% | +24.4% | +26.2% | +22.2% | -491.9% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $533,774 | $5.42M | $2.37M | $5.79M | $6.08M | $7.26M | $8.97M | $2.44M | $2.00M | $1.60M |
| Operating Income? | -$1.75M | -$2.58M | -$5.55M | -$5.40M | -$5.54M | -$5.26M | -$10.67M | -$2.44M | -$2.00M | -$1.60M |
| EBITDA? | $18,186 | $2.39M | -$4.75M | -$5.36M | -$1.94M | -$2.03M | -$8.65M | -$3.48M | -$3.12M | -$1.60M |
| Income Before Tax | -$416,675 | -$583,200 | -$8.02M | -$9.14M | -$4.78M | -$5.23M | -$10.02M | -$4.34M | -$3.86M | -$1.60M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$416,675 | -$583,200 | -$8.02M | -$11.10M | -$6.12M | -$6.99M | -$9.48M | -$4.34M | -$3.86M | -$1.60M |
| EPS? | $-0.01 | $-0.03 | $-0.48 | $-0.75 | $-0.34 | $-0.41 | $-7.83 | $-25.49 | $-0.23 | $-18.68 |
| Diluted EPS? | $-0.01 | $-0.03 | $-0.48 | $-0.75 | $-0.34 | $-0.41 | $-7.83 | $-25.49 | $-0.23 | $-18.68 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality